Parkinson's disease
Valted Seq Lands Exclusive Rights to Evaluate Johns Hopkins Neurodegenerative Disease Dx Assays
The biomarker assays could one day be used as companion diagnostics for new treatments of Parkinson's and related diseases.
Centogene Q4 Revenues Grow Almost Fivefold, Driven by COVID-19 Testing
For 2020, the company reported €128.4 million in revenues, including €89.3 million from COVID-19 testing, more than doubling its 2019 revenues of €48.8 million.
Neurodegenerative Disease Testing Firm CND Life Sciences Closes $2.4M Seed Financing Round
The financing will go toward the expansion of the company's laboratory operations and acceleration of the sales and marketing efforts of its Syn-One Test.
Norwegian Startup Pre Diagnostics Developing Monocyte Test for Presymptomatic Alzheimer's Disease
Premium
The firm said its test detects biomarkers inside monocyte blood cells that reflect the reduced clearance of amyloid-beta plaque that leads to Alzheimer's disease.
Ardigen, BioCollective Partner to Discover Metagenomic Biomarkers of Parkinson's Disease
The companies aim to identify biomarkers that can be used to diagnose early-onset Parkinson's disease, as well as track disease progression.
Jul 17, 2019
Aug 15, 2018
Sep 15, 2017
Jul 12, 2017